Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment

Hepat Med. 2022 Sep 29:14:135-161. doi: 10.2147/HMER.S377530. eCollection 2022.

Abstract

Polycystic liver disease (PLD) is a clinical condition characterized by the presence of more than 10 cysts in the liver. It is a rare disease Of genetic etiology that presents as an isolated disease or assoc\iated with polycystic kidney disease. Ductal plate malformation, ciliary dysfunction, and changes in cell signaling are the main factors involved in its pathogenesis. Most patients with PLD are asymptomatic, but in 2-5% of cases the disease has disabling symptoms and a significant reduction in quality of life. The diagnosis is based on family history of hepatic and/or renal polycystic disease, clinical manifestations, patient age, and polycystic liver phenotype shown on imaging examinations. PLD treatment has evolved considerably in the last decades. Somatostatin analogues hold promise in controlling disease progression, but liver transplantation remains a unique curative treatment modality.

Keywords: hepatomegaly; liver; liver cysts; polycystic liver disease; therapeutics.

Publication types

  • Review

Grants and funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.